Peapack Gladstone Financial Corp Sorrento Therapeutics, Inc. Transaction History

Peapack Gladstone Financial Corp

  • $6.94 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.51 - $2.88 $137 - $262
-91 Reduced 0.88%
10,200 $16,000
Q1 2022

May 16, 2022
BUY
$2.0 - $4.9 $182 - $445
91 Added 0.89%
10,291 $24,000
Q2 2021

Aug 16, 2021
SELL
$6.35 - $10.0 $4,445 - $7,000
-700 Reduced 6.42%
10,200 $99,000
Q1 2021

May 14, 2021
BUY
$7.03 - $16.51 $4,921 - $11,557
700 Added 6.86%
10,900 $90,000
Q4 2020

Feb 16, 2021
BUY
$5.76 - $11.95 $58,752 - $121,890
10,200 New
10,200 $70,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email